Skip to main content

Spondyloarthritis News

Related terms: Spondylitis

Cosentyx Receives FDA Approval for New Indication to Treat Active Non-Radiographic Axial Spondyloarthritis

EAST HANOVER, N.J., June 16, 2020 /PRNewswire/ – Novartis, a leader in rheumatology and immuno-dermatology, today announced that the US Food and Drug Administration (FDA) has approved Cosentyx...

Lilly's Taltz (ixekizumab) is the First IL-17A Antagonist to Receive U.S. FDA Approval for the Treatment of Non-Radiographic Axial Spondyloarthritis (nr-axSpA)

INDIANAPOLIS, June 1, 2020 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (...

FDA Approves Cimzia (certolizumab pegol) for the Treatment for Non-Radiographic Axial Spondyloarthritis

Brussels, Belgium – 29 March 2019 – UCB, a global biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved extending the label for Cimzia (certolizumab ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Psoriatic Arthritis, Ankylosing Spondylitis, Non-Radiographic Axial Spondyloarthritis

Related drug support groups

aspirin, diclofenac, Celebrex, Voltaren, adalimumab, Arthritis Pain, etanercept